Literature DB >> 3486229

Generation of purified stromal cell cultures that support lymphoid and myeloid precursors.

K Dorshkind, A Johnson, L Collins, G M Keller, R A Phillips.   

Abstract

Treatment of Dexter-type long-term bone marrow cultures with the antibiotic mycophenolic acid (MPA) eliminates all hemopoietic cells from the cultures, while a morphologically intact, adherent stromal cell layer is retained. The ability of these MPA treated stromal cell cultures to support long-term hemopoiesis was tested by seeding them with fresh bone marrow cells that had been passed through nylon wool. This procedure yields a relatively stromal cell depleted population of hemopoietic cells. An aliquot of 5 X 10(5) or 2.5 X 10(5) nylon wool passed bone marrow cells bearing the T6 chromosomal marker was seeded onto replicate MPA-treated stromal cell layers. The stromal cells stimulated the proliferation of the bone marrow cells, and nonadherent cells were present for up to 8 weeks of culture. Progenitors of granulocytes and macrophages (CFU-GM) were also present for this period of time despite weekly demi-depopulation, during culture feeding. Karyotypic analysis confirmed that the CFU-GM were derived from the reseeded population. Nylon wool-passed bone marrow cells seeded alone into empty flasks under identical conditions did not survive past 1 week. Cells from the reseeded cultures were also tested for early myeloid precursors (CFU-S) and injected into immunodeficient CBA/N mice to test for the presence of primitive B cell precursors. CFU-S were present in mice killed 11 days following injection of cells, and high levels of B cell colony-forming units (CFU-B) were present in mice 4 weeks post reconstitution. Further studies demonstrated that factors present in medium conditioned by the stromal cells could support the growth of CFU-GM. These data indicate that treatment of long-term bone marrow cultures with MPA results in a population of functional stromal cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486229     DOI: 10.1016/0022-1759(86)90029-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  Characteristics of Mesenchymal Stem Cells - New Stars in Regenerative Medicine or Unrecognized Old Fellows in Autologous Regeneration?

Authors:  Richard Schäfer; Hinnak Northoff
Journal:  Transfus Med Hemother       Date:  2008-05-21       Impact factor: 3.747

2.  Hematopoietic progenitor cells grow on 3T3 fibroblast monolayers that overexpress growth arrest-specific gene-6 (GAS6).

Authors:  S P Dormady; X M Zhang; R S Basch
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

3.  A tumor necrosis factor-responsive long-term-culture-initiating cell is associated with the stromal layer of mouse long-term bone marrow cultures.

Authors:  J A Rogers; J W Berman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

4.  One synchronous wave of B cell development in mouse fetal liver changes at day 16 of gestation from dependence to independence of a stromal cell environment.

Authors:  A Strasser; A Rolink; F Melchers
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

5.  Genotype-restricted growth and aging patterns in hematopoietic stem cell populations of allophenic mice.

Authors:  G Van Zant; B P Holland; P W Eldridge; J J Chen
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

6.  Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow.

Authors:  Yoshihiro Ueda; Motonari Kondo; Garnett Kelsoe
Journal:  J Exp Med       Date:  2005-06-06       Impact factor: 14.307

7.  Long-term proliferating early pre B cell lines and clones with the potential to develop to surface Ig-positive, mitogen reactive B cells in vitro and in vivo.

Authors:  A Rolink; A Kudo; H Karasuyama; Y Kikuchi; F Melchers
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.